Expert consensus on the management strategy of patients with hereditary ataxia during prevention and control of novel coronavirus pneumonia epidemic.
10.3760/cma.j.issn.1003-9406.2020.04.001
- Author:
SPECIALIZED COMMITTEE OF NEUROGENETICS NEUROPHYSICIAN BRANCH OF CHINESE MEDICAL DOCTOR ASSOCIATION
1
;
Hong JIANG
;
Beisha TANG
Author Information
1. Department of Neurology, Hunan Provincial Key Laboratory for Neurodegenerative Disorders, National Clinical Medical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, Hunan 410083, China. jianghong73868@126.com.
- Publication Type:Journal Article
- MeSH:
Betacoronavirus;
China;
epidemiology;
Consensus;
Coronavirus Infections;
complications;
epidemiology;
Epidemics;
Health Status;
Humans;
Mental Health;
Nervous System Diseases;
virology;
Pandemics;
Pneumonia, Viral;
complications;
epidemiology;
Spinocerebellar Degenerations;
complications;
diagnosis;
prevention & control;
therapy
- From:
Chinese Journal of Medical Genetics
2020;37(4):359-366
- CountryChina
- Language:Chinese
-
Abstract:
Since December 2019, a series of highly infectious cases of unexplained pneumonia have been discovered in Wuhan, Hubei Province, which have been confirmed as '2019 corona virus disease' caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 virus can invade many human systems including the lungs. Patients with central nervous system involvement may show a series of neurological symptoms, which is easy to be misdiagnosed and neglected, thereby increasing the risk of SARS-CoV-2 transmission. Hereditary ataxia is a large group of neurodegenerative diseases with great clinical and genetic heterogeneity and high mortality and disability. In view of the seriousness of the COVID-19 epidemic, a series of prevention and control measures adopted by the government have restricted the follow-up, diagnosis and treatment of patients by the hospitals, which has a great impact on their mental and physical health. In order to standardize the management of patients during the prevention and control of COVID-19 epidemic, the Specialized Committee of Neurogenetics of the Neurophysician Branch of Chinese Medical Doctor Association has formulated this consensus, with an aim to help patients to overcome the difficulties and pass the epidemic prevention period safely.
